Therapy With Atorvastatin Versus Rosuvastatin Reduces Urinary Podocytes, Podocyte-Associated Molecules, And Proximal Tubule Dysfunction Biomarkers In Patients With Type 2 Diabetes Mellitus: A Pilot Study.

2018-03-07Author:adminpraise:0